DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Cidofoviris the generic ingredient in two branded drugs marketed by Emcure Pharms Ltd, Mylan Institutional, and Gilead Sciences Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.
There are three drug master file entries for cidofovir. Two suppliers are listed for this compound.
Recent Clinical Trials for cidofovir
Identify potential brand extensions & 505(b)(2) entrants
|Hospital Universitari Vall d'Hebron Research Institute||Phase 3|
|University Hospital, Strasbourg, France||Phase 4|
|Assiut University||Phase 3|
Pharmacology for cidofovir
|Drug Class||Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor |
|Mechanism of Action||DNA Polymerase Inhibitors |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mylan Institutional||CIDOFOVIR||cidofovir||INJECTABLE;INJECTION||201276-001||Jun 27, 2012||AP||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|Emcure Pharms Ltd||CIDOFOVIR||cidofovir||INJECTABLE;INJECTION||202501-001||Jul 26, 2012||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Gilead Sciences Inc||VISTIDE||cidofovir||INJECTABLE;INJECTION||020638-001||Jun 26, 1996||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Gilead Sciences Inc||VISTIDE||cidofovir||INJECTABLE;INJECTION||020638-001||Jun 26, 1996||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.